Markets:

Overview

News

Currencies

International

Treasuries

Timber Pharmaceuticals Inc (NY:TMBR)

N/A UNCHANGED

Last Price Updated: 8:00 PM EST, Nov 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Timber Pharmaceuticals Inc

< Previous 1 2 3 4 5 Next >

Timber Pharmaceuticals Receives Court Approval of All First Day Motions to Support Business Operations & Discloses Communication From NYSE American

November 28, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

September 18, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR

August 29, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 ↗

August 28, 2023

Via Benzinga

Crude Oil Falls; Nikola Shares Plummet ↗

August 21, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P...

Via Benzinga

Topics Stocks

Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 21, 2023

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 21, 2023

Via Benzinga

Why Timber Pharmaceuticals Stock Is Skyrocketing Today ↗

August 21, 2023

Timber Pharmaceuticals, Inc. (NYSE: TMBR) has

Via Benzinga

Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher ↗

August 21, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500,...

Via Benzinga

Topics Stocks

TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders

August 21, 2023

From Halper Sadeh LLC

Via Business Wire

Why Is Skillz (SKLZ) Stock Up 20% Today? ↗

August 21, 2023

Skillz (SKLZ) stock is taking off on Monday after the mobile gaming company announced plans for a share repurchase program.

Via InvestorPlace

Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today? ↗

August 21, 2023

Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.

Via InvestorPlace

US Stocks Mostly Higher; Nasdaq Jumps 100 Points ↗

August 21, 2023

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 21, 2023

Via Benzinga

Timber Pharmaceuticals to be Acquired by LEO Pharma

August 21, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 18, 2023

Via Benzinga

Timber Pharmaceuticals Discloses Communication From NYSE American

July 03, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

June 20, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 06, 2023

Via Benzinga

Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket ↗

June 06, 2023

Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading.

Via Benzinga

Dow Drops Over 100 Points; Crude Oil Rises ↗

June 05, 2023

U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 05, 2023

Via Benzinga

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

Nasdaq Rises 70 Points; ISM Services PMI Drops In May ↗

June 05, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,...

Via Benzinga

Timber Pharmaceuticals’ (NYSE American: TMBR) Phase 3 ASCEND Study for TMB-001: A Leap Forward in Congenital Ichthyosis Treatment

June 05, 2023

Significant Progress in Timber Pharmaceuticals' Phase 3 ASCEND Study Timber Pharmaceuticals (NYSE American: TMBR), a clinical-stage biopharmaceutical company specializing in

Via Spotlight Growth

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 05, 2023

Via Benzinga

Why Are Timber Pharmaceuticals Shares Trading Higher Today ↗

June 05, 2023

The FDA has granted dermal carcinogenicity (CARC) waiver for Timber Pharmaceuticals Inc's (NYSE: TMBR) TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system.

Via Benzinga

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

June 05, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

May 15, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.